E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/10/2006 in the Prospect News Biotech Daily.

Serono ends talks on selling company, calling bids too low

By E. Janene Geiss

Philadelphia, April 10 - Serono SA announced Monday that its controlling shareholder, the Bertarelli family, has terminated discussions concerning a sale of the company. The family has indicated that the offers it received did not adequately reflect the future prospects of the company.

"Moving forward, Serono will invest in its existing businesses and will actively pursue opportunities for growth through acquisitions," Ernesto Bertarelli, chief executive officer, said in a company news release.

To provide the company with the financing to pursue those alternatives, officials said, the board of directors will ask the annual shareholders meeting on April 25 to approve an increase in the authorized share capital of the company. The change will enable the board to obtain financing rapidly through the issuance of additional shares, officials said.

Serono is a Geneva, Switzerland, biotechnology company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.